GOOD PRACTICE SYMPOSIA

MONDAY 7 - FRIDAY 11 MARCH 2022

VIRTUAL SYMPOSIA

About

We are delighted to announce the return of the Medicines and Healthcare products Regulatory Agency (MHRA) Good Practice Symposia week, a week-long series of events taking place from Monday 7 March – Friday 11 March 2022. 

The MHRA Good Practice Symposia week will provide you with insight into key topics, compliance trends and the opportunity to hear first-hand from MHRA Inspectors and speakers from US Food and Drug Administration (FDA) and Health Canada (HC).   

The Good Practice Symposia week will comprise of the following events:

Good Clinical Practice
Monday 7 – Wednesday 9 March 2022, 12:30-16:30 GMT

This three day event is in partnership with Health Canada and the US Food and Drug Administration (FDA).

This virtual workshop follows previous joint events between the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) and the US Food and Drug Administration’s (FDA), Center for Drug Evaluation and Research (CDER) including Workshops in October 2018: ‘Data Integrity in Global Clinical Trials- Are We There Yet?’ and February 2020: ‘Data Integrity in Global Clinical Trials Tackling Challenging Topics.’

At the March 2022 event, the MHRA and FDA welcome Health Canada (HC) to the collaboration.

Click through for further information on this year’s event including ticket options.

Good Pharmacovigilance Symposium
Thursday 10 – Friday 11 March 2022, 12:00-16:45

The 2022 Good Pharmacovigilance (GPvP) Symposium will deliver insightful discussions on   the key topics and compliance trends in pharmacovigilance, observed by MHRA GPvP inspectors since the 2020 Symposium.

This two-day event is relevant to anyone working in pharmacovigilance, medical information and regulatory affairs, including UK QPPVs and service providers.

Click through for further information on this year’s event including ticket options.